Commit To Purchase Kythera Biopharmaceuticals At $30, Earn 12.1% Annualized Using Options
August 28, 2014 at 11:32 AM EDT
Investors considering a purchase of Kythera Biopharmaceuticals, Inc. (KYTH) shares, but cautious about paying the going market price of $37.18/share, might benefit from considering selling puts among the alternative strategies at their disposal..